Simran Maggo
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Treatment of Major Depression
Papers in
- Pharmacology 13
- Pharmacogenetics and Drug Metabolism 13
- Treatment of Major Depression 2
-
- Receptor Mechanisms and Signaling 3
- Co-authors
- Martin A. Kennedy (19 shared papers)David W. J. Clark (2 shared papers)John C. Ashton (4 shared papers)Paul K. L. Chin (4 shared papers)Allison L. Miller (7 shared papers)Ruth Savage (2 shared papers)Simone L. Cree (3 shared papers)John F. Pearson (3 shared papers)
- Journals
- Frontiers in Genetics (5 papers)Pharmacogenetics and Genomics (3 papers)Drug Safety (2 papers)European Journal of Pharmacology (2 papers)Frontiers in Pharmacology (1 paper)
- Partner nations
- New ZealandUnited StatesMalaysia
In The Last Decade
Simran Maggo
25 papers receiving 346 citations
Peers
Comparison fields: 5 of 68
- Pharmacology 118
- Toxicology 12
- Pharmacology 49
- Biological Psychiatry 7
- Surgery 70
Countries citing papers authored by Simran Maggo
This map shows the geographic impact of Simran Maggo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simran Maggo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simran Maggo more than expected).
Fields of papers citing papers by Simran Maggo
This network shows the impact of papers produced by Simran Maggo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simran Maggo. The network helps show where Simran Maggo may publish in the future.
Co-authors
The 25 scholars most cited alongside Simran Maggo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 57 | |
| 2 | 2020 | 45 | |
| 3 | 2019 | 38 | |
| 4 | 2011 | 25 | |
| 5 | 2018 | 17 | |
| 6 | 2015 | 17 | |
| 7 | 2013 | 16 | |
| 8 | 2011 | 15 | |
| 9 | 2019 | 13 | |
| 10 | 2023 | 11 | |
| 11 | 2022 | 11 | |
| 12 | 2019 | 11 | |
| 13 | A New Zealand platform to enable genetic investigation of adverse drug reactions. | 2017 | 9 |
| 14 | 2019 | 8 | |
| 15 | 2024 | 8 | |
| 16 | 2011 | 8 | |
| 17 | 2019 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2017 | 6 | |
| 20 | 2018 | 6 |
About Simran Maggo
Simran Maggo is a scholar working on Pharmacology, Molecular Biology, Pharmacology, Surgery and Pediatrics, Perinatology and Child Health, having authored 32 papers that have together received 355 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (13 papers), Computational Drug Discovery Methods (3 papers), Receptor Mechanisms and Signaling (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Pharmaceutical studies and practices (3 papers), Neuroscience and Neuropharmacology Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Treatment of Major Depression (2 papers). The work is most often cited by research in Pharmacology (118 citations), Toxicology (12 citations), Pharmacology (49 citations), Biological Psychiatry (7 citations) and Surgery (70 citations). Simran Maggo has collaborated with scholars based in New Zealand, United States and Malaysia. Frequent co-authors include Martin A. Kennedy, David W. J. Clark, John C. Ashton, Paul K. L. Chin, Allison L. Miller, Ruth Savage, Simone L. Cree, John F. Pearson, Ming Tan and Jack Rivers‐Auty. Their work appears in journals such as Frontiers in Genetics, Pharmacogenetics and Genomics, Drug Safety, European Journal of Pharmacology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.